| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Laboratory of Respiratory Biology, National Institutes of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709
Received 22 November 2006/ Accepted 20 December 2006
Asthma is characterized as a chronic inflammatory disease associated with significant tissue remodeling. Patients with asthma are more susceptible to virus-induced exacerbation, which subsequently can lead to increased rates of hospitalization and mortality. While the most common cause of asthma-related deaths is respiratory viral infections, the underlying factors in the lung environment which render asthmatic subjects more susceptible to viral exacerbation are not yet identified. Since transforming growth factor ß (TGF-ß) is a critical cytokine for lung tissue remodeling and asthma phenotype, we have focused on the effects of TGF-ß on viral replication and virus-induced inflammation. Treatment of human epithelial cells with TGF-ß increased respiratory syncytial virus (RSV) replication by approximately fourfold. Tumor necrosis factor alpha (TNF-
) mRNA and protein expression were also significantly increased above levels with RSV infection alone. The increase in RSV replication and TNF-
expression after TGF-ß treatment was concomitant with an increase in virus-induced p38 mitogen-activated protein kinase activation. Our data reveal a novel effect for TGF-ß on RSV replication and provide a potential mechanism for the exaggerated inflammatory response observed in asthmatic subjects during respiratory viral infections.
Published ahead of print on 3 January 2007.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|